Search Results

Tuna has similar impact on white women, USC research suggests.

The indication of decreased risk was seen across all types of coffee, both caffeinated and decaffeinated.

Two stories dominated Alzheimer's news this year: The FDA's approval of Leqembi, the first drug to slow progression of the disease, and a surprising study showing that mild cognitive impairment is wildly underdiagnosed. USC researchers are available to discuss.

Among older Americans surveyed in the weeks after FDA approval of aducanumab, few could correctly answer true or false questions about the first new Alzheimer’s drug in decades.

A randomized trial shows cycles of a five-day fasting diet designed by a USC researcher safely reduces the risk factors for age-related diseases.

What if you could lose weight and reduce your risk of life-threatening disease without any changes in what you eat — other than a five-day special diet once every few months? That’s what happened for 71 adults who were placed on three cycles of a low-calorie, “fasting-mimicking†diet. The phase II trial, conducted by researchers at the USC Leonard Davis School of Gerontology, demonstrated a host of benefits from the regimen.

Burdened by tragedy and pain, USC alumnus Michael Washington almost gave up on life. Now he helps other first responders find hope and healing.

A mutation in a microprotein is connected to a significant increase in the risk for Alzheimer’s and highlights a possible target for treatment, a USC Leonard Davis School of Gerontology study finds.